Anti-HER2 therapy for metastatic breast cancer in low- and middle-income countries: bridging the gap between clinical trials and real life.
Leonardo Ribeiro SoaresVictor Domingos Lisita RosaRuffo Freitas-JuniorPublished in: Breast cancer research and treatment (2020)